Outpatient hysteroscopies and endometrial biopsies are probably not performed more widely in Britain because of the lack of managerial support in providing the facilities to establish clinics specifically for these procedures. Finding the time to perform biopsy and hysteroscopy in a busy gynaecological clinic, with 15 or 20 new referrals, is difficult. Considerable financial savings may result, however, from treating women in outpatient clinics. The continuing widespread use of an operation that is diagnostically inaccurate and therapeutically useless is hard to justify.
Assessing hospital technology in the Netherlands
New treatments are paidfor only ifthey are part ofan evaluation Most developed countries struggle to control the influx of new and expensive technologies into hospitals by attempting to ensure-with varying degrees of success-that a technology is evaluated before it is widely diffused. In the Netherlands a system has now evolved that should ensure that no medical technology is introduced before clinicians and health planners know whether-and for which patients-it works.
Although health care in the Netherlands is financed by a mixture of public and private funding, the power to control hospital care lies with the minister of health and the Health Insurance Council, a national body representing all the parties responsible for providing and funding health care. A mandatory insurance system for everyone whose income is below a certain amount covers about 60% ofthe population and 65% of the total costs. Central government contributes about 1O0%, and the remaining 25% comes from private insurance and direct payments. Except for the eight university hospitals and a few municipal facilities Dutch acute hospitals are privately run non-profit institutions, but they need approval from the minister of health before they can be reimbursed for treating patients under the mandatory insurance scheme. The 
